Laboratorios Farmaceuticos Rovi Overview

  • Founded
  • 1946
Founded
  • Status
  • Public
  • Employees
  • 1,419
Employees
  • Stock Symbol
  • ROVI
Stock Symbol
  • Investments
  • 1
  • Share Price
  • $50.26
  • (As of Friday Closing)

Laboratorios Farmaceuticos Rovi General Information

Description

Laboratorios Farmaceuticos Rovi SA is a biotechnology company engaged in the research, development, manufacturing, and marketing of small molecule and specialty biologic drugs. The company has a diversified portfolio of products that it markets in Spain through its specialized sales force of specialist physicians, hospitals and pharmacies. Laboratorios' research and development pipeline is focused on the expansion of applications, indications, and alternative mechanisms of action for heparin-derived products. The company aims to obtain new pharmaceutical products that enable the regular administration of formulations that are administered daily in chronic and prolonged treatments.

Contact Information

Website
Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Stock Exchange
XMAD
Primary Office
  • Calle José Isbert, 2
  • 28223 Madrid
  • Spain
+34 910 00 00 00
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Laboratorios Farmaceuticos Rovi Stock Performance

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$50.26 $51.81 $21.85 - $58.09 $2.78B 55.4M 68.1K $1.25

Laboratorios Farmaceuticos Rovi Financials Summary

In Thousands,
USD
TTM 31-Dec-2020 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018
EV 2,540,827 2,540,827 1,515,660 1,130,940
Revenue 478,719 478,719 426,859 357,800
EBITDA 105,985 105,985 67,942 34,718
Net Income 69,600 69,600 43,964 21,117
Total Assets 706,541 706,541 572,644 460,650
Total Debt 90,425 90,425 94,852 39,149
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Laboratorios Farmaceuticos Rovi Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Laboratorios Farmaceuticos Rovi‘s full profile, request access.

Request a free trial

Laboratorios Farmaceuticos Rovi Executive Team (3)

Name Title Board Seat Contact Info
Juan Encina Chief Executive Officer
Javier Encina Chief Financial Officer & Second Vice Chairman
Pablo Jorge Chief Economic and Administrative Officer
To view Laboratorios Farmaceuticos Rovi’s complete executive team members history, request access »

Laboratorios Farmaceuticos Rovi Board Members (1)

Name Representing Role Since
000000 000000 Laboratorios Farmaceuticos Rovi Chief Financial Officer & Second Vice Chairman 000 0000
To view Laboratorios Farmaceuticos Rovi’s complete board members history, request access »

Laboratorios Farmaceuticos Rovi Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Laboratorios Farmaceuticos Rovi Investments (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000 (0000000000 00 15-Feb-2019 000000000 00000 00 000.00 Buildings and Property 0000 000000
To view Laboratorios Farmaceuticos Rovi’s complete investments history, request access »